The present trial will provide information on the effect of implementing a feasible intervention, where all children receive BCG at their first health-facility contact. Consent is obtained from all ...

The New Drug Application for TAR-200 is supported by results from the Phase IIb SunRISe-1 study, which demonstrated an 83.5% complete response in patients with Bacillus Calmette-Guérin-unresponsive ...

A new drug application has been initiated with the FDA for TAR-200 to treat BCG-unresponsive HR-NMIBC with CIS, with or without papillary tumors. 1 The submission is being reviewed under the FDA's ...

[Kipsang Joseph/Standard] A nationwide shortage of Bacillus Calmette-Guerin (BCG) vaccines is leaving Kenyan newborns vulnerable to Tuberculosis (TB), a disease with high prevalence, health ...

The Boston Consulting Group (BCG) is ranked among the most prestigious consulting firms to work for. One of the renowned Big Three consultancies, BCG is also a major recruiter of MBA and business ...

The study evaluates MRK’s pulmonary arterial hypertension (PAH) drug, Winrevair (sotatercept), for a more advanced version of the disease. This decision is based on strong efficacy data from ...

Raritan: Johnson & Johnson has announced it has initiated the submission of an original New Drug Application with the U.S. Food and Drug Administration (FDA) for TAR-200 for the treatment of patients ...

What is your approach to discussing treatment options with patients, especially when considering the long-term financial impact of different therapies? With all the available treatments on market, ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

Drugs like Ozempic and Wegovy were already off to fast starts because of their ability to help treat Type 2 diabetes and improve weight loss for millions of Americans. But a new study suggests ...